Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Dingliang Zhu, Harold Bays, Pingjin Gao, Michaela Mattheus, Birgit Voelker & Luis M Ruilope. (2013) Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial. Integrated Blood Pressure Control 6, pages 1-14.
Read now
Read now
Articles from other publishers (4)
Pollen Yeung, Zhaolin Xu & Dena Seeto. (2014) Diltiazem Reduces Mortality and Breakdown of ATP in Red Blood Cell Induced by Isoproterenol in a Freely Moving Rat Model in Vivo. Metabolites 4:3, pages 775-789.
Crossref
Crossref
Alessandro Filippi, Diego Sangiorgi, Stefano Buda, Luca Degli Esposti, Giulio Nati, Italo Paolini & Antonino Di Guardo. (2013) How many hypertensive patients can be controlled in “real life”: an improvement strategy in primary care. BMC Family Practice 14:1.
Crossref
Crossref
Carlos M. Ferrario, Sumeet Panjabi, Paul Buzinec & Jason P. Swindle. (2013) Clinical and economic outcomes associated with amlodipine/renin–angiotensin system blocker combinations. Therapeutic Advances in Cardiovascular Disease 7:1, pages 27-39.
Crossref
Crossref
U. Zeymer, R. Dechend, E. Deeg, E. Kaiser, J. Senges, D. Pittrow & R. Schmieder. (2012) Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry. International Journal of Clinical Practice 66:3, pages 251-261.
Crossref
Crossref